Companies included in IHE
This is IHE's own dated portfolio constitution. Share counts are the calculation basis for constituent revenue and earnings analytics; rounded weights are reference values only. This page shows positions 1–59 of 59.
| Ticker | Issuer | Shares owned | Unit | Reported weight |
|---|---|---|---|---|
| JNJ | JOHNSON & JOHNSON | 942,632 | NS | 23.027485% |
| ELI LILLY AND COMPANY | ELI LILLY AND COMPANY | 229,087 | NS | 21.057739% |
| MRK | MERCK & CO., INC. | 394,200 | NS | 4.738907% |
| PFE | PFIZER INC. | 1,678,022 | NS | 4.70898% |
| RPRX | ROYALTY PHARMA PLC | 981,152 | NS | 4.703683% |
| BRISTOL-MYERS SQUIBB COMPANY | BRISTOL-MYERS SQUIBB COMPANY | 763,754 | NS | 4.629311% |
| ZTS | ZOETIS INC. | 382,419 | NS | 4.517787% |
| BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares | BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares | 43,573,038.561 | NS | 4.355487% |
| VTRS | VIATRIS INC. | 3,219,194 | NS | 4.346449% |
| ELAN | ELANCO ANIMAL HEALTH INCORPORATED | 1,388,731 | NS | 3.321184% |
| JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY | JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY | 169,838 | NS | 3.208807% |
| AXSM | AXSOME THERAPEUTICS, INC. | 118,359 | NS | 1.99927% |
| Terns Pharmaceuticals Inc | Terns Pharmaceuticals Inc | 240,429 | NS | 1.26676% |
| LIGAND PHARMACEUTICALS INCORPORATED | LIGAND PHARMACEUTICALS INCORPORATED | 55,011 | NS | 1.097617% |
| INDV | INDIVIOR PHARMACEUTICALS, INC. | 348,967 | NS | 1.062995% |
| CORT | CORCEPT THERAPEUTICS INCORPORATED | 261,660 | NS | 1.054101% |
| CRNX | Crinetics Pharmaceuticals Inc | 286,520 | NS | 1.039999% |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | 160,263 | NS | 0.827888% |
| PBH | PRESTIGE CONSUMER HEALTHCARE INC. | 132,257 | NS | 0.783404% |
| TARS | Tarsus Pharmaceuticals Inc | 109,154 | NS | 0.765243% |
| LQDA | Liquidia Corp | 192,090 | NS | 0.724501% |
| EWTX | Edgewise Therapeutics Inc | 207,131 | NS | 0.65206% |
| AMRX | AMNEAL PHARMACEUTICALS, INC. | 474,468 | NS | 0.5894% |
| NKTR | NEKTAR THERAPEUTICS | 78,204 | NS | 0.562331% |
| DFTX | Definium Therapeutics Inc | 275,332 | NS | 0.520057% |
| ALMS | Alumis Inc | 226,551 | NS | 0.498784% |
| ELVN | Enliven Therapeutics Inc | 124,406 | NS | 0.487371% |
| INVA | INNOVIVA, INC. | 198,530 | NS | 0.46229% |
| OGN | ORGANON & CO. | 726,652 | NS | 0.434996% |
| PERRIGO COMPANY PUBLIC LIMITED COMPANY | PERRIGO COMPANY PUBLIC LIMITED COMPANY | 384,659 | NS | 0.412869% |
| OCUL | OCULAR THERAPEUTIX, INC. | 486,759 | NS | 0.412031% |
| ANIP | ANI PHARMACEUTICALS, INC. | 50,247 | NS | 0.386161% |
| TRVI | Trevi Therapeutics Inc | 290,306 | NS | 0.346121% |
| HROW | HARROW, INC. | 92,131 | NS | 0.324654% |
| AMLX | Amylyx Pharmaceuticals Inc | 233,280 | NS | 0.324059% |
| PAHC | PHIBRO ANIMAL HEALTH CORPORATION | 57,644 | NS | 0.318632% |
| HRMY | HARMONY BIOSCIENCES HOLDINGS, INC. | 111,077 | NS | 0.310935% |
| WVE | WAVE Life Sciences Ltd | 404,066 | NS | 0.292767% |
| COLL | Collegium Pharmaceutical, Inc. | 88,352 | NS | 0.292% |
| NUVB | Nuvation Bio Inc | 668,795 | NS | 0.286736% |
| EYPT | EYEPOINT, INC. | 217,506 | NS | 0.280192% |
| XERS | XERIS BIOPHARMA HOLDINGS, INC. | 463,758 | NS | 0.268814% |
| PCRX | PACIRA BIOSCIENCES, INC. | 114,720 | NS | 0.259107% |
| RAPP | Rapport Therapeutics Inc | 79,927 | NS | 0.249937% |
| MBX | MBX Biosciences Inc | 70,280 | NS | 0.209656% |
| OMER | OMEROS CORPORATION | 198,165 | NS | 0.209133% |
| AMPH | AMPHASTAR PHARMACEUTICALS, INC. | 98,895 | NS | 0.193616% |
| ARVN | Arvinas Inc | 179,506 | NS | 0.190159% |
| MAZE | Maze Therapeutics Inc | 59,177 | NS | 0.176534% |
| TBPH | THERAVANCE BIOPHARMA, INC. | 103,389 | NS | 0.167697% |
| LBRX | LB Pharmaceuticals Inc | 67,960 | NS | 0.167486% |
| PHAT | PHATHOM PHARMACEUTICALS, INC. | 139,379 | NS | 0.154755% |
| SEPN | Septerna Inc | 63,823 | NS | 0.153272% |
| BIOA | BIOAGE Labs Inc | 84,022 | NS | 0.146864% |
| CRMD | CORMEDIX INC. | 204,800 | NS | 0.138973% |
| BlackRock Funds III: BlackRock Cash Funds: Treasury; SL Agency Shares | BlackRock Funds III: BlackRock Cash Funds: Treasury; SL Agency Shares | 901,593.79 | NS | 0.090104% |
| EOLS | Evolus Inc | 181,171 | NS | 0.074415% |
| LENZ | LENZ Therapeutics Inc | 61,219 | NS | 0.055981% |
| 1XAVM26 | XAV HEALTH CARE JUN26 | 8 | NC | -0.003347% |
SEC N-PORT snapshot as of .